Hereditary Cancer
MUTYH and Serrated Polyposis
MAP syndrome, the serrated pathway, surveillance intervals, and surgery thresholds
Beyond Lynch and classic FAP, two important pathways are MUTYH biallelic disease (MAP) and serrated polyposis syndrome (SPS). Not every polyp means the same syndrome — type, number, and age drive suspicion. Plans should not lock without genetic counseling when hereditary risk is on the table.
A single MUTYH variant is not automatic MAP. SPS is often a clinical diagnosis. Colectomy is not as automatic as in classic FAP — burden, dysplasia, and preference are weighed together.
MUTYH-associated polyposis (MAP)
MAP is defined by biallelic pathogenic MUTYH variants. Autosomal recessive inheritance means family history can look quiet — parents may be carriers without polyposis. Typical findings include multiple adenomas and sometimes early CRC; hundreds of polyps like classic FAP are not required.
- Biallelic variants required (one allele ≠ MAP)
- Recessive inheritance → quiet family history possible
- Adenoma burden varies
- Counseling + written consent required
Serrated polyposis syndrome (SPS)
SPS is defined by clinical criteria based on sessile serrated / hyperplastic polyp burden or early CRC along the serrated pathway. Genetic panels are not always positive — diagnosis often rests on endoscopic and pathologic burden. Tight colonoscopy intervals and complete polypectomy are central.
- Serrated / sessile lesion burden
- Clinical criteria often lead
- Tight colonoscopy intervals
- Resection discussed if cancer concern rises
How this differs from FAP and Lynch
FAP usually involves APC and very high adenoma counts with lower prophylactic colectomy thresholds. Lynch follows MMR/MSI and organ-specific surveillance; polyp counts may be modest. MAP/SPS can sit between these classic profiles — the wrong label means the wrong interval.
Surveillance and family
For MAP, intervals for the affected person and first-degree relatives are set with counseling. For SPS, intervals stay tight based on burden. Sibling / child testing follows the inheritance model — one panel for everyone is not correct.
Surgery thresholds
Very high polyp burden, endoscopically unmanageable lesions, high-grade dysplasia, or cancer may lead to colectomy / proctocolectomy. Restorative choices (anastomosis vs stoma) depend on sphincter status, rectal involvement, and preference — do not copy FAP protocols blindly.
- Is endoscopic control still possible?
- Is there dysplasia or cancer?
- Can the rectum be preserved?
- Has stoma / pouch need been discussed?
Common questions
- Does one MUTYH variant mean MAP?Tap for details
No. MAP requires biallelic variants. A monoallelic finding needs counseling — not panic or automatic colectomy.
- How is this different from FAP?Tap for details
FAP involves APC and often hundreds of adenomas with earlier surgery thresholds. MAP/SPS have different polyp biology and inheritance.
- Is genetic testing mandatory in SPS?Tap for details
Clinical diagnosis can rest on endoscopic criteria. Testing is selective; a negative panel does not exclude SPS.
- Is surgery always required?Tap for details
No. Many people are managed with tight colonoscopy and polypectomy. Surgery follows burden or dysplasia / cancer.
Evidence
Scientific sources
Show sources · 2Counseling frameworks for MAP and serrated polyposis surveillance and surgery thresholds.
Evidence
Scientific sources
- 1. NCCN Clinical Practice Guidelines in Oncology: Colon CancerNational Comprehensive Cancer Network (NCCN) · Güncel sürüm / Current versionOpen source →
- 2. ASCRS clinical practice guidelines libraryAmerican Society of Colon & Rectal Surgeons (ASCRS) · Kılavuz kütüphanesi / Guideline libraryOpen source →
Last reviewed: 21 August 2026. Links go to publisher pages.
Bu sayfalar bilgilendirme amaçlıdır; genetik tanı, test siparişi veya kişisel risk skoru yerine geçmez. Germline test ve aile taraması genetik danışmanlık eşliğinde planlanır.